Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fluocinonide recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Fluocinonide (12 total). Check the affected lots below.

Most common reason: Stability / shelf life (4 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluocinonide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fluocinonide recalls in 2026

3 initiated in 2026, 12 in total — newest first
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-3 D-0477-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-2 D-0476-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-1 D-0475-2026
Class II · Moderate risk

Fluocinonide Topical Solution USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk

Fluocinonide Gel USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022
Class II · Moderate risk

Fluocinonide Cream USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-079-11 D-0683-2022
Class III · Low risk

Fluocinonide Gel USP

Cross contamination with other products: traces of Dapsone were found in the finished product.

Terminated Cross-contamination Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1279-1 D-0146-2018
Class III · Low risk

Fluocinonide Cream UPS

Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.

Terminated Cross-contamination Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1254-3 D-0790-2017
Class II · Moderate risk

Fluocinonide Gel USP

Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.

Terminated Stability / shelf life Fougera Pharmaceuticals Inc. NDC 0168-0135-15 D-0245-2015